--- title: "PFIZER ApS – CVR 66351912, financials and ownership" description: "PFIZER ApS (CVR 66351912): Pfizer is a pharmaceutical company that develops medicines and treatments, conducts research, and collaborates with authorities, physicians, healthcare professionals, and patient associations." canonical_url: "https://datapublica.dk/en/companies/66351912-pfizer-aps" locale: "en" route_type: "company_overview" robots: "index,follow" --- # PFIZER ApS PFIZER ApS \(CVR 66351912\): Pfizer is a pharmaceutical company that develops medicines and treatments, conducts research, and collaborates with authorities, physicians, healthcare professionals, and patient associations. CVR number: 66351912 ## Company details - **CVR number:** 66351912 - **Status:** Aktiv - **Address:** Lautrupvang 8, 2750, Ballerup - **Legal form:** Anpartsselskab \(ApS\) - **Founded:** Jan 16, 1956 - **Employees / FTEs:** 71 / 69 - **Production units:** 1 - **Website:** https://www.pfizer.dk/ - **LEI:** 549300L8RUV11VG54E78 ## Description Pfizer is a pharmaceutical company that develops medicines and treatments, conducts research, and collaborates with authorities, physicians, healthcare professionals, and patient associations. Pfizer works to improve the lives of patients and relatives by researching, developing, and providing innovative treatments and medicines. It also provides targeted information and continuing education for healthcare professionals. ### Company's own description on virk.dk ActivitiesPfizer and its worldwide affiliates are a research-based, global biopharmaceutical company. Pfizer works across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. In the context of its global operations, Pfizer applies science and global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sales, and distribution of biopharmaceutical products to fulfill Pfizer’s purpose: Breakthroughs that change patients’ lives.Pfizer ApS is a fully owned subsidiary of Pfizer Inc. and performs sales and marketing functions and purchases finished products from supply point companies for resale to third parties. Pfizer ApS operates as non-exclusive distributor in Denmark, selling to local wholesalers, pharmacies, and government facilities, as well as to a third-party distributor in Iceland. As a local market company, it utilizes technical materials prepared centrally by the R&D and Commercial organizations to present scientific data and information to explain the approved uses, benefits, and risks of Pfizer’s products.Research and development activitiesResearch and development activities within the Biopharma division of Pfizer ApS comprise clinical trials, regulatory affairs, drug safety and medical affairs. The Pharmaceutical division of Pfizer ApS only performs research and development on behalf of other group enterprises. Pfizer ApS does not acquire ownership to intellectual rights. ### Products & services Medicines • Treatments • Innovative treatment forms • Targeted information and continuing education for healthcare professionals ### Industries Pharmaceuticals • Healthcare • Life sciences ### Customer types Patients and relatives • Healthcare professionals • Authorities • Physicians • Patient associations ## Analysis by AI ✨ In the 2025 financial year, revenue fell to DKK 683.2 million from DKK 847.5 million the previous year, while profit for the year rose to DKK 14 million from DKK 13.1 million. The financial year ran from 1 December 2024 to 30 November 2025. The company had 70 employees and 69 full-time equivalents \(FTE\) in July 2026. In July 2025, the figures were 86 employees and 82 FTE. [Pfizer Health AB](https://datapublica.dk/en/participants/pid_owner_enhed_4008863479-pfizer-health-ab) \(Sweden\) has been the direct legal owner of PFIZER ApS since 7 April 2021. The previous direct owner was [Wyeth AB](https://datapublica.dk/en/participants/pid_owner_enhed_4005899758-wyeth-ab) \(Sweden\), from 23 September 2014 to 7 April 2021. PFIZER ApS owned [Seagen Denmark ApS](https://datapublica.dk/en/companies/40738576) from 3 May to 26 August 2024. The annual report says Seagen Denmark ApS was transferred to Pfizer ApS as part of a merger plan and merged with Pfizer ApS effective 26 August 2024. AI-generated texts are based on registered information, which may be delayed or incomplete. Errors may occur. ## Activities and industry - Engroshandel med medicinalvarer og sygeplejeartikler - 464610 — Engroshandel med medicinalvarer og sygeplejeartikler ## Latest financial period - **Reporting period:** 2024/25 \(1 Dec 2024 - 30 Nov 2025\) - **Currency:** DKK - **Revenue:** 683,240,000 - **Gross profit:** 150,536,000 - **Operating profit:** 17,284,000 - **Profit after tax:** 13,956,000 - **Assets:** 397,978,000 - **Equity:** 315,053,000 ## People | Person | Roles | Titles | | --- | --- | --- | | [Anne Bloch Thomsen](https://datapublica.dk/en/people/pid_entity_4008409006-anne-bloch-thomsen) | Board | FORMAND | | [Hans Henrik Buur](https://datapublica.dk/en/people/pid_entity_4010581466-hans-henrik-buur) | Board | BESTYRELSESMEDLEM | | [Kjetil Hagen](https://datapublica.dk/en/people/pid_entity_4009249818-kjetil-hagen) | Board • Management | BESTYRELSESMEDLEM • ADM. DIR. | ## Auditor | Audit firm | Auditor | Role | From | | --- | --- | --- | --- | | KPMGStatsautoriseret Revisionspartnerselskab | Sara Carstensen | State Authorised Public Accountant | May 29, 2026 | ## Contact ### From [cvr.dk](https://datacvr.virk.dk/) | Contact | Phone | Email | | --- | --- | --- | | Company | 4420\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F66351912-pfizer-aps) | — | Branches \(1\) Pfizer Consumer HealthCare · Sydmarken 5 · P-1018984012 | Contact | Phone | Email | | --- | --- | --- | | Company | 3958\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F66351912-pfizer-aps) | — | ### From [pfizer.dk](https://www.pfizer.dk/) | Contact | Phone | Email | | --- | --- | --- | | Pfizer Danmark | 44 20 \*\* \*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F66351912-pfizer-aps) | — | ## Legal owners ### Current | Owner | Ownership | Voting rights | From | | --- | --- | --- | --- | | OwnerPfizer Health AB | Ownership100 % | Voting rights100 % | FromApr 7, 2021 | ### Previous | Owner | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | OwnerWyeth AB | Ownership100 % | Voting rights100 % | FromSep 23, 2014 | ToApr 7, 2021 | ## Child companies ### Previous | Company | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | CompanySeagen Denmark ApS | Ownership100 % | Voting rights100 % | FromMay 3, 2024 | ToAug 26, 2024 | ## Ultimate owners [View ownership diagram](https://datapublica.dk/en/companies/66351912-pfizer-aps/portfolio) | Name | Ownership through | Calculated ownership | | --- | --- | --- | | Pfizer Health AB | Direct | 100 % | ## Company pages - [Overview](https://datapublica.dk/en/companies/66351912-pfizer-aps) - [Financial report](https://datapublica.dk/en/companies/66351912-pfizer-aps/financials) - [Risk](https://datapublica.dk/en/companies/66351912-pfizer-aps/risk) - [Timeline](https://datapublica.dk/en/companies/66351912-pfizer-aps/timeline) - [Ownership and relations](https://datapublica.dk/en/companies/66351912-pfizer-aps/portfolio) - [Production units](https://datapublica.dk/en/companies/66351912-pfizer-aps/production-units) - [Gazelle](https://datapublica.dk/en/companies/66351912-pfizer-aps/gazelle) - [Investments](https://datapublica.dk/en/companies/66351912-pfizer-aps/investments) - [Company website](https://www.pfizer.dk/) ## Official sources - [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/66351912) - [Official LEI record at GLEIF](https://www.gleif.org/)